The French National Agency for the Safety of Medicines and Health Products (ANSM) has authorised FineHeart to commence a ...

Nat Clin Pract Cardiovasc Med. 2006;3(7):346-347. Since the first widespread clinical application of left ventricular assist devices (LVADs) for patients with end-stage heart failure in the ...

The HeartMate II is currently the only continuous-flow left-ventricular assist device (LVAD) approved by the FDA for both bridge-to-transplantation and destination therapy. Because of its ...

What has put a rocket under this stock on Friday? Let's find out. The post Why this ASX All Ords stock is jumping 9% today ...

FineHeart announced today that French regulators gave it the green light to initiate a first-in-human heart device trial in ...

The groundbreaking, seven-hour procedure was carried out at Hadassah Ein Kerem Medical Center by an extensive medical team ...